Osaic Holdings’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$249K Sell
97,359
-55,166
-36% -$141K ﹤0.01% 3416
2025
Q1
$459K Buy
152,525
+54,978
+56% +$165K ﹤0.01% 2951
2024
Q4
$250K Sell
97,547
-5,645
-5% -$14.4K ﹤0.01% 3403
2024
Q3
$384K Buy
103,192
+28,338
+38% +$105K ﹤0.01% 3112
2024
Q2
$473K Buy
74,854
+31,697
+73% +$200K ﹤0.01% 2821
2024
Q1
$232K Buy
43,157
+12,609
+41% +$67.7K ﹤0.01% 3564
2023
Q4
$153K Buy
30,548
+1,843
+6% +$9.25K ﹤0.01% 4137
2023
Q3
$48.5K Buy
28,705
+15,827
+123% +$26.7K ﹤0.01% 5019
2023
Q2
$35.8K Sell
12,878
-10,635
-45% -$29.6K ﹤0.01% 5153
2023
Q1
$42.8K Sell
23,513
-2,556
-10% -$4.65K ﹤0.01% 5050
2022
Q4
$133K Sell
26,069
-9,213
-26% -$47K ﹤0.01% 4206
2022
Q3
$176K Buy
35,282
+2,763
+8% +$13.8K ﹤0.01% 3869
2022
Q2
$122K Buy
32,519
+20,128
+162% +$75.5K ﹤0.01% 4246
2022
Q1
$69K Buy
12,391
+754
+6% +$4.2K ﹤0.01% 4847
2021
Q4
$71K Sell
11,637
-20,184
-63% -$123K ﹤0.01% 4868
2021
Q3
$309K Buy
31,821
+18,783
+144% +$182K ﹤0.01% 3519
2021
Q2
$186K Buy
13,038
+8,768
+205% +$125K ﹤0.01% 3909
2021
Q1
$102K Buy
4,270
+2,420
+131% +$57.8K ﹤0.01% 4316
2020
Q4
$24K Sell
1,850
-7,650
-81% -$99.2K ﹤0.01% 5010
2020
Q3
$67K Buy
9,500
+8,520
+869% +$60.1K ﹤0.01% 4097
2020
Q2
$12K Buy
980
+382
+64% +$4.68K ﹤0.01% 5055
2020
Q1
$2K Buy
+598
New +$2K ﹤0.01% 5594